Stueland Katherine Insider Trades & Stock Holdings

CHIEF EXECUTIVE OFFICER · GeneDx Holdings Corp. · Latest filing Sep 16, 2026

Stueland Katherine, CHIEF EXECUTIVE OFFICER at GeneDx Holdings Corp. has 1 Form 4 trade on file since Sep 16, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($1.03M), net -$1.03M. Latest filing: disposed of 10.50K shares of $WGS on Sep 16, 2026 at $97.61.

Trades on file

1

Open-market bought

$0

Open-market sold

$1.03M

Net open-market

-$1.03M

Latest filing

Sep 16, 2026

All insider trades by Stueland Katherine

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 16, 2026	$WGS	Sell (Open-market sale)	10.50K	$97.61	$1.03M			-12.5%	-34.7%		CHIEF EXECUTIVE OFFICER		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Stueland Katherine traded

• $WGS

Frequently asked questions

Has Stueland Katherine been buying or selling stock?

Stueland Katherine has 0 open-market purchases and 1 open-market sale on file, net -$1.03M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Stueland Katherine's latest insider trade?

disposed of 10.50K shares of $WGS on Sep 16, 2026 at $97.61.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.